TY - JOUR
T1 - Radiotherapy for nasopharyngeal carcinoma
AU - Maingon, P.
AU - Blanchard, P.
AU - Bidault, F.
AU - Calmels, L.
N1 - Publisher Copyright:
© 2016
PY - 2016/9/1
Y1 - 2016/9/1
N2 - Nasapharyngeal carcinoma is a rare disease. Oftenly, the diagnostic is made for advanced disease. Localized tumors, T1 or T2 NO observed a good prognosis and are locally controlled in more than 90 % of the cases by radiotherapy alone. The standard treatment of locally advanced disease is combined chemoradiation. A special vigilance of fast decrease of the volume of the pathological lymph nodes, sometimes associated to loss of weight might indicate an adaptive dosimetric revision. The treatment of recurrent disease is of great importance. Surgical indications are limited but should be discussed in multidisciplinary tumor board when possible. Surgical nodal sampling has to be proposed for nodal recurrence as well as reirradiation, which could be indicated according to the technical issues.
AB - Nasapharyngeal carcinoma is a rare disease. Oftenly, the diagnostic is made for advanced disease. Localized tumors, T1 or T2 NO observed a good prognosis and are locally controlled in more than 90 % of the cases by radiotherapy alone. The standard treatment of locally advanced disease is combined chemoradiation. A special vigilance of fast decrease of the volume of the pathological lymph nodes, sometimes associated to loss of weight might indicate an adaptive dosimetric revision. The treatment of recurrent disease is of great importance. Surgical indications are limited but should be discussed in multidisciplinary tumor board when possible. Surgical nodal sampling has to be proposed for nodal recurrence as well as reirradiation, which could be indicated according to the technical issues.
KW - Adaptive radiotherapy
KW - Chemoradiation
KW - Intensity modulated radiotherapy
KW - Nasopharynx
UR - http://www.scopus.com/inward/record.url?scp=84981748053&partnerID=8YFLogxK
U2 - 10.1016/j.canrad.2016.07.031
DO - 10.1016/j.canrad.2016.07.031
M3 - Short survey
C2 - 27523419
AN - SCOPUS:84981748053
SN - 1278-3218
VL - 20
SP - S104-S109
JO - Cancer/Radiotherapie
JF - Cancer/Radiotherapie
ER -